Oct 15, 2025 | Press Releases
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE Mass., October 15, 2025 — TriNetX, driven by its vision of a connected world where data and...
Sep 29, 2025 | Press Releases
Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation. CAMBRIDGE Mass., September 25, 2025 — TriNetX, the company behind the world’s broadest federated...
Jul 31, 2025 | Press Releases
Analysis reveals strategic opportunities for pharmaceutical leaders to close treatment gaps and accelerate breakthroughs in underserved rare disease communities. Cambridge, MA, July 31, 2025 — TriNetX, driven by its vision of a connected world where data and...
Jul 10, 2025 | Press Releases
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum. CAMBRIDGE, MA – July 10, 2025 – As...
Feb 12, 2025 | Press Releases
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. Cambridge, MA, February 12, 2025 — TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu,...
Jan 9, 2025 | Press Releases
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board CAMBRIDGE, MA – January 9, 2025 – TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step...
